Zobrazeno 1 - 10
of 101
pro vyhledávání: '"Leonard B. Weinstock"'
Publikováno v:
Journal of Personalized Medicine, Vol 13, Iss 11, p 1562 (2023)
Mast cell activation syndrome (MCAS) is an immune disease with an estimated prevalence of 17%. Mast cell chemical mediators lead to heterogeneous multisystemic inflammatory and allergic manifestations. This syndrome is associated with various neurolo
Externí odkaz:
https://doaj.org/article/69094875257b4f98ac5c6359a06f0426
Autor:
Leonard B. Weinstock, Jill B. Brook, Arthur S. Walters, Ashleigh Goris, Lawrence B. Afrin, Gerhard J. Molderings
Publikováno v:
International Journal of Infectious Diseases, Vol 112, Iss , Pp 217-226 (2021)
Objectives: Hyper-inflammation caused by COVID-19 may be mediated by mast cell activation (MCA) which has also been hypothesized to cause Long-COVID (LC) symptoms. We determined prevalence/severity of MCA symptoms in LC. Methods: Adults in LC-focused
Externí odkaz:
https://doaj.org/article/db453fa00119469cb16d24c614ced8ea
Publikováno v:
International Journal of Infectious Diseases, Vol 100, Iss , Pp 327-332 (2020)
Objectives: One-fifth of Covid-19 patients suffer a severe course of Covid-19 infection; however, the specific causes remain unclear. Mast cells (MCs) are activated by SARS-CoV-2. Although only recently recognized, MC activation syndrome (MCAS), usua
Externí odkaz:
https://doaj.org/article/e9bfcec1eb6e4d6b967ce54498eac174
Restless Legs Syndrome Shows Increased Silent Postmortem Cerebral Microvascular Disease With Gliosis
Autor:
Arthur S. Walters, Paisit Paueksakon, Charles H. Adler, Michael Moussouttas, Leonard B. Weinstock, Karen Spruyt, Kanika Bagai
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 10, Iss 11 (2021)
Background Patients with restless legs syndrome (RLS) have increased silent microvascular disease by magnetic resonance imaging. However, there has been no previous autopsy confirmation of these magnetic resonance imaging findings. RLS is also freque
Externí odkaz:
https://doaj.org/article/88f052d333d04674b849d90c9350a975
Publikováno v:
Vaccines, Vol 10, Iss 1, p 127 (2022)
For nearly a decade, case reports and series have emerged regarding dysautonomias—particularly postural orthostatic tachycardia syndrome (POTS)—presenting soon after vaccination against human papilloma virus (HPV). We too have observed a number o
Externí odkaz:
https://doaj.org/article/f4c9c88dbf80442fb39971a3728b2247
Autor:
Tomasz Zienkiewicz, Jürgen Homann, Martin Mücke, Holger Seidel, Hans-Jörg Hertfelder, Leonard B. Weinstock, Lawrence B. Afrin, Gerhard J. Molderings
Publikováno v:
Zeitschrift für Gastroenterologie. 61:268-274
Laboratory evidence supporting diagnosis of the prevalent condition of mast cell activation syndrome (MCAS) currently includes elevated levels in blood or urine of mediators relatively specific to mast cells (MCs) and/or increased numbers of MCs in l
Autor:
Arthur S. Walters, Yuqing Li, Elias G. Karroum, David Champion, Leonard B. Weinstock, Kanika Bagai, Lawrence B. Afrin, Karen Spruyt
Publikováno v:
Med Hypotheses
Restless Legs Syndrome (RLS) is characterized by bothersome leg discomfort accompanied by an urge to move to obtain relief and symptoms are worse at night and on lying down. There is at least partial and temporary relief with activity. It is also an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02a8aac9da55557044bce8f77a832d64
https://europepmc.org/articles/PMC9731170/
https://europepmc.org/articles/PMC9731170/
Autor:
Leonard B. Weinstock, Angela M. Reiersen, Anshu Jain, Katerina Konstantinoff, William James, Farid Jalali
Publikováno v:
ACG Case Reports Journal. 10:e01034
Autor:
Leonard B. Weinstock, Jill B. Brook, Arthur S. Walters, Ashleigh Goris, Lawrence B. Afrin, Gerhard J. Molderings
Publikováno v:
J Clin Sleep Med
STUDY OBJECTIVES: Sleep disturbance is common in long-COVID (LC). Restless legs syndrome (RLS) is characterized by sleep disturbance and has been reported after viral infections. Therefore, we evaluated RLS symptoms cross-sectionally in individuals w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::029a84190a8dc4c6d9781782775ed1cc
https://europepmc.org/articles/PMC9059584/
https://europepmc.org/articles/PMC9059584/
Publikováno v:
Naunyn-Schmiedeberg's archives of pharmacology. 395(11)
Determine efficacy and adverse events (AEs) of hydroxyurea (HU) in mast cell activation syndrome (MCAS) patients who were refractory to standard medical therapy. An electronic chart review was performed to find MCAS patients who received HU in a MCAS